
Sign up to save your podcasts
Or
According to the U.S. Department of Justice, pharmaceutical giant Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs. The settlement resolves a lawsuit filed and litigated by former Biogen employee Michael Bawduniak against Biogen under the qui tam or whistleblower provisions of the federal False Claims Act. Famed whistleblower Mary Inman will report this story during the next live edition of Monitor Mondays. Inman, reporting from her London office, is expected to provide details on the settlement.
Other segments will include these instantly recognizable broadcast segments:
4.5
2323 ratings
According to the U.S. Department of Justice, pharmaceutical giant Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs. The settlement resolves a lawsuit filed and litigated by former Biogen employee Michael Bawduniak against Biogen under the qui tam or whistleblower provisions of the federal False Claims Act. Famed whistleblower Mary Inman will report this story during the next live edition of Monitor Mondays. Inman, reporting from her London office, is expected to provide details on the settlement.
Other segments will include these instantly recognizable broadcast segments:
43,920 Listeners
90,584 Listeners
1,301 Listeners
111,112 Listeners
55,946 Listeners
485 Listeners
40 Listeners
57 Listeners
1,082 Listeners
388 Listeners
13,298 Listeners
12,074 Listeners
16,187 Listeners
4,351 Listeners
6,254 Listeners